Parkinson's disease (PD) is a progressive neurodegenerative disorder that primarily affects the motor system. It is characterized by bradykinesia, rigidity, resting tremor, and postural instability. The disease is associated with the degeneration of dopaminergic neurons in the substantia nigra and the presence of Lewy bodies.
The etiology of PD is multifactorial, involving a complex interplay of genetic and environmental factors. The primary pathophysiological feature is the loss of dopaminergic neurons in the substantia nigra pars compacta. This neuronal loss leads to a reduction in striatal dopamine levels, resulting in motor symptoms. The presence of Lewy bodies, composed mainly of alpha-synuclein, is another pathological hallmark.
Patients typically present with asymmetric motor symptoms, including resting tremor, bradykinesia, rigidity, and postural instability. Non-motor symptoms such as autonomic dysfunction, cognitive impairment, and mood disorders may also be present. The diagnosis is primarily clinical, based on the presence of cardinal motor symptoms and response to dopaminergic therapy.
Treatment of PD is symptomatic, aiming to improve quality of life. Pharmacological therapy is the mainstay of treatment, with levodopa being the most effective drug. Other medications include dopamine agonists, MAO-B inhibitors, and COMT inhibitors. In advanced stages, surgical interventions like deep brain stimulation may be considered.
While significant strides have been made in understanding PD, it remains a challenging disease to manage due to its progressive nature and the complexity of its symptomatology. Early recognition and an individualized, multidisciplinary approach to management can significantly improve patient outcomes. As healthcare professionals, continuous education and staying abreast with the latest research is crucial in providing optimal care to these patients.
1.
A Lot Can Be Said About You by Including Yourself in Photos.
2.
A new blood test greatly increases the ability to detect cancer.
3.
Novel biomarker has potential for predicting and treating skin cancer metastasis
4.
Anti-PD-L1 Plus Targeted Agent No Better Than Chemo for Resistant NSCLC
5.
No Survival Gain With Preoperative CRT Plus Perioperative Chemo for Gastric Cancer
1.
Preventing Heparin Induced Thrombocytopenia: Tips for Successful Anticoagulation Therapy
2.
Preventing Treatment-Related Secondary Malignancies: Evidence-Based Strategies for Clinical Practice
3.
Contemporary Frameworks in Oncology Across Clinical Settings
4.
What is Mullerian and How Does it Affect Your Health
5.
The Expanding Horizon of PSMA: A Comparative Clinical Review of Theranostics in Prostate Cancer and Beyond
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Understanding Common Causes of Abnormal Blood Counts
2.
Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites
3.
CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion
4.
Understanding Cancer: Early Detection and Treatment
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation